Composition and method for treating keratosis pilaris
View Patent ↗A combination comprising buffered glycolic acid, urea, and white tea extract for treating keratosis pilaris is provided. The improved composition provides a significant and unexpected reduction of KP symptoms when applied topically to an affected area.
1. A composition for treating keratosis pilaris, wherein the composition comprises:
from about 0.01% to 60% buffered glycolic acid;
from about 0.01% to 50% urea;
from about 0.01% to 30.0% salicylic acid;
from about 0.01% to 30.0% azelaic acid;
from about 0.01% to 30.0% lactic acid; and
at least 0.01% of a tea extract selected from the group consisting of white tea extract and a mixture consisting of white tea extract and green tea extract.
2. The composition of claim 1 , wherein the composition further comprises at least one skin lightening agent.
3. The composition of claim 2 , wherein the at least one skin lightening agent is a skin lightening agent selected from the group consisting of alpha hydroxy acids, beta hydroxy acids, Vitamin A, Vitamin A derivatives, sutilains, tyrosinase receptor blockers, Vitamin C, Vitamin C derivatives, melanin inhibitors and mixtures thereof.
4. The composition of claim 3 , wherein the Vitamin A derivatives is a Vitamin A derivative selected from the group consisting of tretinoin, iso-treninoin, retinol, retinyl palmitate, retinoic acid, tazarotene, adapalene and mixtures thereof.
5. The composition of claim 1 , wherein the composition further comprises at least one component selected from the group consisting of organic acids, herbs, vitamins, minerals, steroidal compounds, essential oils, immunosuppressants, topical anesthetics, tyronase inhibitors, antihistamines, antibiotics, antibacterials, antifungals, flavinoids, analgesics, soluble fiber and mixtures thereof.
6. A composition for treating keratosis pilaris, wherein the composition comprises:
from about 5% to 20% buffered glycolic acid;
from about 1% to 10% urea;
from about 0.1% to 5% salicylic acid;
from about 0.1% to 5% azelaic acid;
from about 0.1% to 5% lactic acid; and
at least 1% of a tea extract selected from the group consisting of white tea extract and a mixture consisting of white tea extract and green tea extract.
7. The composition of claim 6 , wherein said composition further comprises at least one skin lightening agent.
8. The composition of claim 7 , wherein the at least one skin lightening agent is a skin lightening agent selected from the group consisting of alpha hydroxy acids, beta hydroxy acids, Vitamin A, Vitamin A derivatives, sutilains, tyrosinase receptor blockers, Vitamin C, Vitamin C derivatives, melanin inhibitors and mixtures thereof.
9. The composition of claim 8 , wherein the Vitamin A derivatives comprise a Vitamin A derivative selected from the group consisting of tretinoin, iso-treninoin, retinol, retinyl palmitate, retinoic acid, tazarotene, adapalene and mixtures thereof.
10. The composition of claim 6 , further comprising at least one component selected from the group consisting of organic acids, herbs, vitamins, minerals, steroidal compounds, essential oils, immunosuppressants, topical anesthetics, tyronase inhibitors, antihistamines, antibiotics, antibacterials, antifungals, flavinoids, analgesics, soluble fiber and mixtures thereof.
11. A composition for treating keratosis pilaris, wherein the composition comprises:
about 12% buffered glycolic acid;
about 5% urea;
about 2% salicylic, acid;
about 1% azelaic acid;
about 3% lactic acid; and
about 5% of a tea extract selected from the group consisting of white tea extract and a mixture consisting of white tea extract and green tea extract.
12. The composition of claim 11 , further comprising at least one skin lightening agent.
13. The composition of claim 12 , wherein the at least one skin lightening agent comprises a skin lightening agent selected from the group consisting of alpha hydroxy acids, beta hydroxy acids, Vitamin A, Vitamin A derivatives, sutilains, tyrosinase receptor blockers, Vitamin C, Vitamin C derivatives, melanin inhibitors and mixtures thereof.
14. The composition of claim 13 , wherein the Vitamin A derivatives comprise a Vitamin A derivative selected from the group consisting of tretinoin, iso-treninoin, retinol, retinyl palmitate, retinoic acid, tazarotene, adapalene and mixtures thereof.
15. The composition of claim 12 , further comprising at least one component selected from the group consisting of organic acids, herbs, vitamins, minerals, steroidal compounds, essential oils, immunosuppressants, topical anesthetics, tyronase inhibitors, antihistamines, antibiotics, antibacterials, antifungals, flavonoids, analgesics, soluble fiber and mixtures thereof.